Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Other Non Operating Income (2021 - 2025)

Journey Medical (DERM) has disclosed Other Non Operating Income for 5 consecutive years, with -$3000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non Operating Income fell 100.27% year-over-year to -$3000.0, compared with a TTM value of $1.2 million through Sep 2025, up 8.22%, and an annual FY2024 reading of $1.1 million, up 714.75% over the prior year.
  • Other Non Operating Income was -$3000.0 for Q3 2025 at Journey Medical, up from -$61000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $1.2 million in Q4 2024 and bottomed at -$263000.0 in Q4 2021.
  • Average Other Non Operating Income over 5 years is $94437.5, with a median of -$27000.0 recorded in 2022.
  • The sharpest move saw Other Non Operating Income crashed 1000.0% in 2022, then skyrocketed 61550.0% in 2024.
  • Year by year, Other Non Operating Income stood at -$263000.0 in 2021, then skyrocketed by 74.52% to -$67000.0 in 2022, then surged by 97.01% to -$2000.0 in 2023, then surged by 61550.0% to $1.2 million in 2024, then crashed by 100.24% to -$3000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for DERM at -$3000.0 in Q3 2025, -$61000.0 in Q2 2025, and -$7000.0 in Q1 2025.